NO20051169L - Fremgangsmate for a isolere et intestinalt kolesterolbindende protein - Google Patents

Fremgangsmate for a isolere et intestinalt kolesterolbindende protein

Info

Publication number
NO20051169L
NO20051169L NO20051169A NO20051169A NO20051169L NO 20051169 L NO20051169 L NO 20051169L NO 20051169 A NO20051169 A NO 20051169A NO 20051169 A NO20051169 A NO 20051169A NO 20051169 L NO20051169 L NO 20051169L
Authority
NO
Norway
Prior art keywords
isolating
binding protein
intestinal cholesterol
cholesterol
intestinal
Prior art date
Application number
NO20051169A
Other languages
English (en)
Other versions
NO333437B1 (no
Inventor
Wendelin Frick
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20051169L publication Critical patent/NO20051169L/no
Publication of NO333437B1 publication Critical patent/NO333437B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Sammendrag Oppfinnelsen beskriver en fremgangsmåte for å isolere et intestinalprotein som er i stand til å binde kolesterol og/eller hemmere av kolesterolopptak.
NO20051169A 2002-08-06 2005-03-04 Fremgangsmate for a isolere et intestinalt kolesterolbindende protein, sammensetning samt anvendelse av sammensetningen NO333437B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02017504 2002-08-06
PCT/EP2003/008290 WO2004014947A1 (en) 2002-08-06 2003-07-28 Method for isolating an intestinal cholesterol binding protein

Publications (2)

Publication Number Publication Date
NO20051169L true NO20051169L (no) 2005-05-02
NO333437B1 NO333437B1 (no) 2013-06-03

Family

ID=31502689

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20051169A NO333437B1 (no) 2002-08-06 2005-03-04 Fremgangsmate for a isolere et intestinalt kolesterolbindende protein, sammensetning samt anvendelse av sammensetningen
NO20130115A NO20130115L (no) 2002-08-06 2013-01-18 Farmasøytisk sammensetning omfattende et intestinalt kolesterolbindende protein.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20130115A NO20130115L (no) 2002-08-06 2013-01-18 Farmasøytisk sammensetning omfattende et intestinalt kolesterolbindende protein.

Country Status (17)

Country Link
US (2) US7435727B2 (no)
EP (1) EP1529061B1 (no)
JP (1) JP4575772B2 (no)
KR (1) KR101095288B1 (no)
CN (1) CN1330667C (no)
AT (1) ATE386053T1 (no)
AU (1) AU2003253341C1 (no)
BR (1) BR0313217A (no)
CA (1) CA2493487C (no)
DE (1) DE60319093T2 (no)
HK (1) HK1082509A1 (no)
IL (2) IL166492A (no)
MX (1) MXPA05001264A (no)
NO (2) NO333437B1 (no)
RU (1) RU2345089C2 (no)
WO (1) WO2004014947A1 (no)
ZA (1) ZA200500053B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
AU2004303742B2 (en) 2003-12-23 2008-06-19 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
EP1723414A4 (en) 2004-01-16 2008-03-26 Merck & Co Inc NPC1L1 (NPC3) AND METHOD FOR IDENTIFYING ITS LIGANDS
CN101243072A (zh) 2005-06-20 2008-08-13 先灵公司 用作组胺h3拮抗剂的哌啶衍生物
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
WO2007100807A2 (en) 2006-02-24 2007-09-07 Schering Corporation Npc1l1 orthologues
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN1869704B (zh) * 2006-06-14 2010-06-30 厦门大学 快速鉴定与病原菌互作的宿主蛋白的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710469A (en) * 1986-05-02 1987-12-01 Merck & Co., Inc. Novel phosphotyrosyl protein phosphatase
CA2002607C (en) 1988-11-10 2004-01-27 Gordon G. Wong Natural killer stimulatory factor
ES2168091T3 (es) * 1990-05-16 2002-06-01 Genetics Inst Proteinas de induccion osea y cartilaginosa.
US5264372A (en) 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
US5518911A (en) 1995-01-06 1996-05-21 Onyx Pharmaceuticals, Inc. Human PAK65
JP3088681B2 (ja) 1997-05-22 2000-09-18 宮城県 形質膜局在シアリダーゼ及びそれをコードするｄｎａ
US6383734B1 (en) 1998-09-30 2002-05-07 Advanced Research And Technology Institute, Inc. Method to determine inhibition of PAK3 activation of Raf-1
JP2000166545A (ja) * 1998-12-07 2000-06-20 Snow Brand Milk Prod Co Ltd 胆汁酸活性化リパーゼ
AU3566200A (en) 1999-04-01 2000-10-23 Astrazeneca Uk Limited Human signal transduction serine/threonine protein kinase
AU4343500A (en) * 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
DE10042447A1 (de) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports

Also Published As

Publication number Publication date
CN1330667C (zh) 2007-08-08
DE60319093T2 (de) 2009-02-05
BR0313217A (pt) 2005-06-14
US7435727B2 (en) 2008-10-14
AU2003253341C1 (en) 2009-09-24
US20080167451A1 (en) 2008-07-10
ZA200500053B (en) 2006-07-26
JP4575772B2 (ja) 2010-11-04
NO333437B1 (no) 2013-06-03
IL166492A0 (en) 2006-01-15
CA2493487C (en) 2013-01-22
JP2006512054A (ja) 2006-04-13
US20040126812A1 (en) 2004-07-01
RU2345089C2 (ru) 2009-01-27
US7786103B2 (en) 2010-08-31
AU2003253341A1 (en) 2004-02-25
ATE386053T1 (de) 2008-03-15
RU2005106238A (ru) 2005-08-27
WO2004014947A1 (en) 2004-02-19
DE60319093D1 (de) 2008-03-27
CA2493487A1 (en) 2004-02-19
KR101095288B1 (ko) 2011-12-16
KR20060015443A (ko) 2006-02-17
IL199409A (en) 2010-12-30
EP1529061B1 (en) 2008-02-13
CN1668642A (zh) 2005-09-14
EP1529061A1 (en) 2005-05-11
AU2003253341B2 (en) 2009-04-23
HK1082509A1 (en) 2006-06-09
IL166492A (en) 2010-12-30
MXPA05001264A (es) 2005-04-28
NO20130115L (no) 2005-05-02

Similar Documents

Publication Publication Date Title
NO20051169L (no) Fremgangsmate for a isolere et intestinalt kolesterolbindende protein
NO20052547D0 (no) System og fremgangsmate for foretrukken applikasjonsinstallasjon og -eksekvering.
PL1702066T3 (pl) Sposób i urządzenie do oczyszczania kwasów nukleinowych
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DK1620551T3 (da) Phospholipase og fremgangsmåde til fremstilling deraf
DE60234464D1 (de) Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung
DE60328844D1 (de) Verfahren zur Tonererstellung
IL177308A0 (en) Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
DE602005009856D1 (de) Verfahren zur reinigung von fsh
EP1642136A4 (en) PROCESS FOR THE ISOLATION OF A PROTEIN
DE602005011756D1 (de) Prozessor, verfahren und computerprogrammprodukte zur durchführung von befehlen für effiziente bitstromextraktionen
DE60308433D1 (de) Verfahren für Türanordnung
DE50303241D1 (de) Verfahren zur bereitstellung von abwesenheitsinformation
NO20043705L (no) System og fremgangsmate for kjoring av foring
DE602004004334D1 (de) Bearbeitungsverfahren zur Bearbeitung von gewölbten Oberflächen
AU2003258542A8 (en) Method for isolating atp binding proteins by means of immobolized protein inhibitors
ATE321832T1 (de) Verfahren zur aufbereitung von oliven
ATE539085T1 (de) Verfahren zur isolierung von haptoglobin
ATA14432002A (de) Verbessertes verfahren zur singlet sauerstoff oxidation von organischen substraten
ITRM20020588A1 (it) Metodo per isolare anticorpi intracellulari neutralizzanti di interazioni proteiche.
DE60326551D1 (de) Verfahren zur isomerisierung von kohlenwasserstoffen
ATE415492T1 (de) Verfahren zum identifizieren von makrocyclischen polyketiden
DE10393819D2 (de) Verfahren zum Auffinden geeigneter chromatographiebedingungen zur Trennung biologischer Moleküle
DE10393625D2 (de) Verfahren zum Isolieren von Drehschwingungen
AT500424B1 (de) Verfahren zum sanieren von rohrleitungen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees